PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia
VIEW · 16.11.2026
DOI: 10.1002/viw2.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift VIEW, online erschienen am 16.11.2026. Verfasst von Liang Zhou und 7 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Prostatic fibrosis is an important contributor to the progression and clinical manifestations of benign prostatic hyperplasia (BPH), whereas the underlying molecular mechanisms remain incompletely understood. In this study, integrative multi‐omics analyses, including RNA sequencing, proteomics, and phosphoproteomics, identified p21‐activated kinase 1 (PAK1) as a key regulator associated with prostatic fibrosis. PAK1 expression was markedly increased and was closely associated with the progression of prostatic fibrosis and BPH. Transcriptomic analyses further indicated that the profibrotic effects of PAK1 were closely related to activation of the TGF‐β signaling pathway. Functional experiments demonstrated that PAK1 promoted fibrosis‐related phenotypes and enhanced TGF‐β1 expression. Mechanistically, PAK1‐induced phosphorylation of histone deacetylase 1 (HDAC1) was associated with reduced SP1 acetylation and enhanced SP1‐dependent transcriptional activity, thereby facilitating TGF‐β1 transcription. In vivo, both genetic silencing of PAK1 and pharmacological inhibition with IPA‐3 alleviated prostatic fibrosis and attenuated BPH‐associated pathological changes. Collectively, these findings support a model in which PAK1 contributes to prostatic fibrosis and BPH progression through modulation of the HDAC1/SP1/TGF‐β1 signaling axis and suggest that PAK1 may represent a potential therapeutic target for BPH.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, L., Li, J., Li, Y., Wang, Y., Liu, J., Li, C., Xie, H., & Wang, L. (2026). PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia. VIEW. https://doi.org/10.1002/viw2.70226
Vancouver
Zhou L, Li J, Li Y, Wang Y, Liu J, Li C, et al. PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia. VIEW. 2026. doi:10.1002/viw2.70226
BibTeX
@article{Zhou2026,
author = {Zhou, Liang and Li, Jiaren and Li, Youyou and Wang, Yichuan and Liu, Jiahao and Li, Cheng and Xie, Hui and Wang, Long},
title = {PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia},
journal = {VIEW},
year = {2026},
doi = {10.1002/viw2.70226}
}
EUVIMED